# Relmada Therapeutics, Inc.: Form DEF 14A, filed Apr 17, 2026

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: DEF 14A
- Filed: 2026-04-17
- Accepted by EDGAR: Apr 17, 2026, 16:30 ET
- Period: 2026-05-27
- Accession: 0001213900-26-045192
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm

Filed Apr 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-045192. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.